Home > Research Institute > Available Trials > Trials for high risk prostate cancer evaluating de-intensification and intensification w/radiation
Trials for high risk prostate cancer evaluating de-intensification and intensification w/radiation
Parallel Phase III randomized trials for high risk prostate cancer evaluating de-intensification for lower genomic risk and intensification of concurrent therapy for higher genomic risk with radiation
Disease Types: Prostate
Available at: Roanoke
Parallel Phase III randomized trials for high risk prostate cancer evaluating de-intensification for lower genomic risk and intensification of concurrent therapy for higher genomic risk with radiation
For More Information: